TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Sarcopenia Treatments 1.2 Key Market Segments 1.2.1 Sarcopenia Treatments Segment by Type 1.2.2 Sarcopenia Treatments Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Sarcopenia Treatments Market Overview 2.1 Global Market Overview 2.1.1 Global Sarcopenia Treatments Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Sarcopenia Treatments Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Sarcopenia Treatments Market Competitive Landscape 3.1 Global Sarcopenia Treatments Sales by Manufacturers (2017-2022) 3.2 Global Sarcopenia Treatments Revenue Market Share by Manufacturers (2017-2022) 3.3 Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Sarcopenia Treatments Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Sarcopenia Treatments Sales Sites, Area Served, Product Type 3.6 Sarcopenia Treatments Market Competitive Situation and Trends 3.6.1 Sarcopenia Treatments Market Concentration Rate 3.6.2 Global 5 and 10 Largest Sarcopenia Treatments Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Sarcopenia Treatments Industry Chain Analysis 4.1 Sarcopenia Treatments Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Sarcopenia Treatments Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Sarcopenia Treatments Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Sarcopenia Treatments Sales Market Share by Type (2017-2022) 6.3 Global Sarcopenia Treatments Market Size Market Share by Type (2017-2022) 6.4 Global Sarcopenia Treatments Price by Type (2017-2022) 7 Sarcopenia Treatments Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Sarcopenia Treatments Market Sales by Application (2017-2022) 7.3 Global Sarcopenia Treatments Market Size (M USD) by Application (2017-2022) 7.4 Global Sarcopenia Treatments Sales Growth Rate by Application (2017-2022) 8 Sarcopenia Treatments Market Segmentation by Region 8.1 Global Sarcopenia Treatments Sales by Region 8.1.1 Global Sarcopenia Treatments Sales by Region 8.1.2 Global Sarcopenia Treatments Sales Market Share by Region 8.2 North America 8.2.1 North America Sarcopenia Treatments Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Sarcopenia Treatments Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Sarcopenia Treatments Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Sarcopenia Treatments Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Sarcopenia Treatments Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Abbott Laboratories 9.1.1 Abbott Laboratories Sarcopenia Treatments Basic Information 9.1.2 Abbott Laboratories Sarcopenia Treatments Product Overview 9.1.3 Abbott Laboratories Sarcopenia Treatments Product Market Performance 9.1.4 Abbott Laboratories Business Overview 9.1.5 Abbott Laboratories Sarcopenia Treatments SWOT Analysis 9.1.6 Abbott Laboratories Recent Developments 9.2 Nestlé 9.2.1 Nestlé Sarcopenia Treatments Basic Information 9.2.2 Nestlé Sarcopenia Treatments Product Overview 9.2.3 Nestlé Sarcopenia Treatments Product Market Performance 9.2.4 Nestlé Business Overview 9.2.5 Nestlé Sarcopenia Treatments SWOT Analysis 9.2.6 Nestlé Recent Developments 9.3 Pfizer 9.3.1 Pfizer Sarcopenia Treatments Basic Information 9.3.2 Pfizer Sarcopenia Treatments Product Overview 9.3.3 Pfizer Sarcopenia Treatments Product Market Performance 9.3.4 Pfizer Business Overview 9.3.5 Pfizer Sarcopenia Treatments SWOT Analysis 9.3.6 Pfizer Recent Developments 9.4 Amway 9.4.1 Amway Sarcopenia Treatments Basic Information 9.4.2 Amway Sarcopenia Treatments Product Overview 9.4.3 Amway Sarcopenia Treatments Product Market Performance 9.4.4 Amway Business Overview 9.4.5 Amway Sarcopenia Treatments SWOT Analysis 9.4.6 Amway Recent Developments 9.5 By-health 9.5.1 By-health Sarcopenia Treatments Basic Information 9.5.2 By-health Sarcopenia Treatments Product Overview 9.5.3 By-health Sarcopenia Treatments Product Market Performance 9.5.4 By-health Business Overview 9.5.5 By-health Sarcopenia Treatments SWOT Analysis 9.5.6 By-health Recent Developments 9.6 Usana 9.6.1 Usana Sarcopenia Treatments Basic Information 9.6.2 Usana Sarcopenia Treatments Product Overview 9.6.3 Usana Sarcopenia Treatments Product Market Performance 9.6.4 Usana Business Overview 9.6.5 Usana Recent Developments 9.7 AandZ Pharmaceutical 9.7.1 AandZ Pharmaceutical Sarcopenia Treatments Basic Information 9.7.2 AandZ Pharmaceutical Sarcopenia Treatments Product Overview 9.7.3 AandZ Pharmaceutical Sarcopenia Treatments Product Market Performance 9.7.4 AandZ Pharmaceutical Business Overview 9.7.5 AandZ Pharmaceutical Recent Developments 9.8 GlaxoSmithKline 9.8.1 GlaxoSmithKline Sarcopenia Treatments Basic Information 9.8.2 GlaxoSmithKline Sarcopenia Treatments Product Overview 9.8.3 GlaxoSmithKline Sarcopenia Treatments Product Market Performance 9.8.4 GlaxoSmithKline Business Overview 9.8.5 GlaxoSmithKline Recent Developments 9.9 Bayer 9.9.1 Bayer Sarcopenia Treatments Basic Information 9.9.2 Bayer Sarcopenia Treatments Product Overview 9.9.3 Bayer Sarcopenia Treatments Product Market Performance 9.9.4 Bayer Business Overview 9.9.5 Bayer Recent Developments 9.10 HandH 9.10.1 HandH Sarcopenia Treatments Basic Information 9.10.2 HandH Sarcopenia Treatments Product Overview 9.10.3 HandH Sarcopenia Treatments Product Market Performance 9.10.4 HandH Business Overview 9.10.5 HandH Recent Developments 9.11 Blackmores 9.11.1 Blackmores Sarcopenia Treatments Basic Information 9.11.2 Blackmores Sarcopenia Treatments Product Overview 9.11.3 Blackmores Sarcopenia Treatments Product Market Performance 9.11.4 Blackmores Business Overview 9.11.5 Blackmores Recent Developments 9.12 Zhendong Group 9.12.1 Zhendong Group Sarcopenia Treatments Basic Information 9.12.2 Zhendong Group Sarcopenia Treatments Product Overview 9.12.3 Zhendong Group Sarcopenia Treatments Product Market Performance 9.12.4 Zhendong Group Business Overview 9.12.5 Zhendong Group Recent Developments 10 Sarcopenia Treatments Market Forecast by Region 10.1 Global Sarcopenia Treatments Market Size Forecast 10.2 Global Sarcopenia Treatments Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Sarcopenia Treatments Market Size Forecast by Country 10.2.3 Asia Pacific Sarcopenia Treatments Market Size Forecast by Region 10.2.4 South America Sarcopenia Treatments Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Sarcopenia Treatments by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Sarcopenia Treatments Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Sarcopenia Treatments by Type (2022-2028) 11.1.2 Global Sarcopenia Treatments Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Sarcopenia Treatments by Type (2022-2028) 11.2 Global Sarcopenia Treatments Market Forecast by Application (2022-2028) 11.2.1 Global Sarcopenia Treatments Sales (K Units) Forecast by Application 11.2.2 Global Sarcopenia Treatments Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Sarcopenia Treatments Market Size (M USD) Comparison by Region (M USD) Table 5. Global Sarcopenia Treatments Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Sarcopenia Treatments Sales Market Share by Manufacturers (2017-2022) Table 7. Global Sarcopenia Treatments Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Sarcopenia Treatments Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Treatments as of 2021) Table 10. Global Market Sarcopenia Treatments Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Sarcopenia Treatments Sales Sites and Area Served Table 12. Manufacturers Sarcopenia Treatments Product Type Table 13. Global Sarcopenia Treatments Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Sarcopenia Treatments Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Sarcopenia Treatments Market Challenges Table 22. Market Restraints Table 23. Global Sarcopenia Treatments Sales by Type (K Units) Table 24. Global Sarcopenia Treatments Market Size by Type (M USD) Table 25. Global Sarcopenia Treatments Sales (K Units) by Type (2017-2022) Table 26. Global Sarcopenia Treatments Sales Market Share by Type (2017-2022) Table 27. Global Sarcopenia Treatments Market Size (M USD) by Type (2017-2022) Table 28. Global Sarcopenia Treatments Market Size Share by Type (2017-2022) Table 29. Global Sarcopenia Treatments Price (USD/Unit) by Type (2017-2022) Table 30. Global Sarcopenia Treatments Sales (K Units) by Application Table 31. Global Sarcopenia Treatments Market Size by Application Table 32. Global Sarcopenia Treatments Sales by Application (2017-2022) & (K Units) Table 33. Global Sarcopenia Treatments Sales Market Share by Application (2017-2022) Table 34. Global Sarcopenia Treatments Sales by Application (2017-2022) & (M USD) Table 35. Global Sarcopenia Treatments Market Share by Application (2017-2022) Table 36. Global Sarcopenia Treatments Sales Growth Rate by Application (2017-2022) Table 37. Global Sarcopenia Treatments Sales by Region (2017-2022) & (K Units) Table 38. Global Sarcopenia Treatments Sales Market Share by Region (2017-2022) Table 39. North America Sarcopenia Treatments Sales by Country (2017-2022) & (K Units) Table 40. Europe Sarcopenia Treatments Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Sarcopenia Treatments Sales by Region (2017-2022) & (K Units) Table 42. South America Sarcopenia Treatments Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Sarcopenia Treatments Sales by Region (2017-2022) & (K Units) Table 44. Abbott Laboratories Sarcopenia Treatments Basic Information Table 45. Abbott Laboratories Sarcopenia Treatments Product Overview Table 46. Abbott Laboratories Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Abbott Laboratories Business Overview Table 48. Abbott Laboratories Sarcopenia Treatments SWOT Analysis Table 49. Abbott Laboratories Recent Developments Table 50. Nestlé Sarcopenia Treatments Basic Information Table 51. Nestlé Sarcopenia Treatments Product Overview Table 52. Nestlé Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Nestlé Business Overview Table 54. Nestlé Sarcopenia Treatments SWOT Analysis Table 55. Nestlé Recent Developments Table 56. Pfizer Sarcopenia Treatments Basic Information Table 57. Pfizer Sarcopenia Treatments Product Overview Table 58. Pfizer Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Pfizer Business Overview Table 60. Pfizer Sarcopenia Treatments SWOT Analysis Table 61. Pfizer Recent Developments Table 62. Amway Sarcopenia Treatments Basic Information Table 63. Amway Sarcopenia Treatments Product Overview Table 64. Amway Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Amway Business Overview Table 66. Amway Sarcopenia Treatments SWOT Analysis Table 67. Amway Recent Developments Table 68. By-health Sarcopenia Treatments Basic Information Table 69. By-health Sarcopenia Treatments Product Overview Table 70. By-health Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. By-health Business Overview Table 72. By-health Sarcopenia Treatments SWOT Analysis Table 73. By-health Recent Developments Table 74. Usana Sarcopenia Treatments Basic Information Table 75. Usana Sarcopenia Treatments Product Overview Table 76. Usana Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Usana Business Overview Table 78. Usana Recent Developments Table 79. AandZ Pharmaceutical Sarcopenia Treatments Basic Information Table 80. AandZ Pharmaceutical Sarcopenia Treatments Product Overview Table 81. AandZ Pharmaceutical Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. AandZ Pharmaceutical Business Overview Table 83. AandZ Pharmaceutical Recent Developments Table 84. GlaxoSmithKline Sarcopenia Treatments Basic Information Table 85. GlaxoSmithKline Sarcopenia Treatments Product Overview Table 86. GlaxoSmithKline Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Recent Developments Table 89. Bayer Sarcopenia Treatments Basic Information Table 90. Bayer Sarcopenia Treatments Product Overview Table 91. Bayer Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Bayer Business Overview Table 93. Bayer Recent Developments Table 94. HandH Sarcopenia Treatments Basic Information Table 95. HandH Sarcopenia Treatments Product Overview Table 96. HandH Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. HandH Business Overview Table 98. HandH Recent Developments Table 99. Blackmores Sarcopenia Treatments Basic Information Table 100. Blackmores Sarcopenia Treatments Product Overview Table 101. Blackmores Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Blackmores Business Overview Table 103. Blackmores Recent Developments Table 104. Zhendong Group Sarcopenia Treatments Basic Information Table 105. Zhendong Group Sarcopenia Treatments Product Overview Table 106. Zhendong Group Sarcopenia Treatments Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Zhendong Group Business Overview Table 108. Zhendong Group Recent Developments Table 109. Global Sarcopenia Treatments Sales Forecast by Region (K Units) Table 110. Global Sarcopenia Treatments Market Size Forecast by Region (M USD) Table 111. North America Sarcopenia Treatments Sales Forecast by Country (2022-2028) & (K Units) Table 112. North America Sarcopenia Treatments Market Size Forecast by Country (2022-2028) & (M USD) Table 113. Europe Sarcopenia Treatments Sales Forecast by Country (2022-2028) & (K Units) Table 114. Europe Sarcopenia Treatments Market Size Forecast by Country (2022-2028) & (M USD) Table 115. Asia Pacific Sarcopenia Treatments Sales Forecast by Region (2022-2028) & (K Units) Table 116. Asia Pacific Sarcopenia Treatments Market Size Forecast by Region (2022-2028) & (M USD) Table 117. South America Sarcopenia Treatments Sales Forecast by Country (2022-2028) & (K Units) Table 118. South America Sarcopenia Treatments Market Size Forecast by Country (2022-2028) & (M USD) Table 119. Middle East and Africa Sarcopenia Treatments Consumption Forecast by Country (2022-2028) & (Units) Table 120. Middle East and Africa Sarcopenia Treatments Market Size Forecast by Country (2022-2028) & (M USD) Table 121. Global Sarcopenia Treatments Sales Forecast by Type (2022-2028) & (K Units) Table 122. Global Sarcopenia Treatments Market Size Forecast by Type (2022-2028) & (M USD) Table 123. Global Sarcopenia Treatments Price Forecast by Type (2022-2028) & (USD/Unit) Table 124. Global Sarcopenia Treatments Sales (K Units) Forecast by Application (2022-2028) Table 125. Global Sarcopenia Treatments Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Sarcopenia Treatments Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Sarcopenia Treatments Market Size (M USD), 2017-2028 Figure 5. Global Sarcopenia Treatments Market Size (M USD) (2017-2028) Figure 6. Global Sarcopenia Treatments Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Sarcopenia Treatments Market Size (M USD) by Country (M USD) Figure 11. Sarcopenia Treatments Sales Share by Manufacturers in 2020 Figure 12. Global Sarcopenia Treatments Revenue Share by Manufacturers in 2020 Figure 13. Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Sarcopenia Treatments Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Sarcopenia Treatments Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Sarcopenia Treatments Market Share by Type Figure 18. Sales Market Share of Sarcopenia Treatments by Type (2017-2022) Figure 19. Sales Market Share of Sarcopenia Treatments by Type in 2021 Figure 20. Market Size Share of Sarcopenia Treatments by Type (2017-2022) Figure 21. Market Size Market Share of Sarcopenia Treatments by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Sarcopenia Treatments Market Share by Application Figure 24. Global Sarcopenia Treatments Sales Market Share by Application (2017-2022) Figure 25. Global Sarcopenia Treatments Sales Market Share by Application in 2021 Figure 26. Global Sarcopenia Treatments Market Share by Application (2017-2022) Figure 27. Global Sarcopenia Treatments Market Share by Application in 2020 Figure 28. Global Sarcopenia Treatments Sales Growth Rate by Application (2017-2022) Figure 29. Global Sarcopenia Treatments Sales Market Share by Region (2017-2022) Figure 30. North America Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Sarcopenia Treatments Sales Market Share by Country in 2020 Figure 32. U.S. Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Sarcopenia Treatments Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Sarcopenia Treatments Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Sarcopenia Treatments Sales Market Share by Country in 2020 Figure 37. Germany Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Sarcopenia Treatments Sales and Growth Rate (K Units) Figure 43. Asia Pacific Sarcopenia Treatments Sales Market Share by Region in 2020 Figure 44. China Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Sarcopenia Treatments Sales and Growth Rate (K Units) Figure 50. South America Sarcopenia Treatments Sales Market Share by Country in 2020 Figure 51. Brazil Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Sarcopenia Treatments Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Sarcopenia Treatments Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Sarcopenia Treatments Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Sarcopenia Treatments Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Sarcopenia Treatments Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Sarcopenia Treatments Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Sarcopenia Treatments Market Share Forecast by Type (2022-2028) Figure 65. Global Sarcopenia Treatments Sales Forecast by Application (2022-2028) Figure 66. Global Sarcopenia Treatments Market Share Forecast by Application (2022-2028)

•Abbott Laboratories •Nestlé •Pfizer •Amway •By-health •Usana •AandZ Pharmaceutical •GlaxoSmithKline •Bayer •HandH •Blackmores •Zhendong Group